GlassScriptPhysician profile
Chad Daniel Merrill
NPI 1265135198
$388.56
in general payments reported to CMS, 2019-2025
7 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $104 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $113.75 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $69.50 | 2025 | Dupixent |
| Grifols USA, LLC | $65.80 | 2024-2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $60.35 | 2025 | Nucala |
| Verona Pharma, INC. | $31.85 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $24.18 | 2025 | Fasenra |
| Merck Sharp & Dohme LLC | $23.13 | 2024 | Zerbaxa, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Merrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.